4//SEC Filing
Brown Michael Jon 4
Accession 0001093557-23-000095
CIK 0001093557other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:56 PM ET
Size
8.9 KB
Accession
0001093557-23-000095
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Brown Michael Jon
EVP, Chief Legal Officer
Transactions
- Sale
Common Stock
2023-04-03$114.07/sh−2,409$274,805→ 63,073 total - Sale
Common Stock
2023-04-03$115.08/sh−950$109,330→ 62,123 total - Sale
Common Stock
2023-04-03$116.03/sh−253$29,356→ 61,870 total
Footnotes (4)
- [F1]On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $113.63 to $114.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026.
- [F4]This transaction was executed in multiple trades at prices ranging from $114.70 to $115.45. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001899922
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:56 PM ET
- Size
- 8.9 KB